We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Push Toward Personalized Drug Development Faces Obstacles
Push Toward Personalized Drug Development Faces Obstacles
April 14, 2006
The FDA and the pharma industry face numerous obstacles to implementing a personalized approach to developing new medicines. For the agency, the problems include privacy concerns, financial limits and regulatory roadblocks, says HHS Secretary Mike Leavitt.